S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CompuMed, Inc. stock logo
CMPD
CompuMed
$1.70
$1.71
$1.67
$3.43
$2.18M0.28470 shs100 shs
Akerna Corp. stock logo
KERN
Akerna
$5.89
$0.17
$6.40
$64.92M3.02339,022 shs70,795 shs
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
$0.00
$0.00
$0.00
$0.01
$2.17M3.262.29 million shs7.72 million shs
StageZero Life Sciences Ltd. stock logo
SZLSF
StageZero Life Sciences
$0.03
$0.03
$0.03
$0.06
$3.56M0.6111,998 shs125,025 shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CompuMed, Inc. stock logo
CMPD
CompuMed
0.00%0.00%-1.73%-12.82%-37.27%
Akerna Corp. stock logo
KERN
Akerna
0.00%0.00%0.00%+1.55%-63.11%
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
-11.54%-11.54%-17.86%-42.50%-62.90%
StageZero Life Sciences Ltd. stock logo
SZLSF
StageZero Life Sciences
+35.42%+35.42%+44.44%+35.89%-34.87%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CompuMed, Inc. stock logo
CMPD
CompuMed
N/AN/AN/AN/AN/AN/AN/AN/A
Akerna Corp. stock logo
KERN
Akerna
N/AN/AN/AN/AN/AN/AN/AN/A
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
N/AN/AN/AN/AN/AN/AN/AN/A
StageZero Life Sciences Ltd. stock logo
SZLSF
StageZero Life Sciences
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CompuMed, Inc. stock logo
CMPD
CompuMed
N/AN/AN/AN/A
Akerna Corp. stock logo
KERN
Akerna
N/AN/AN/AN/A
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
N/AN/AN/AN/A
StageZero Life Sciences Ltd. stock logo
SZLSF
StageZero Life Sciences
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CompuMed, Inc. stock logo
CMPD
CompuMed
$5.84M0.37$0.51 per share3.36$2.42 per share0.70
Akerna Corp. stock logo
KERN
Akerna
$13.65M0.00N/AN/A($1.52) per share0.00
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
$810K2.68N/AN/A($0.01) per share-0.23
StageZero Life Sciences Ltd. stock logo
SZLSF
StageZero Life Sciences
$3.80M0.94N/AN/A($0.07) per share-0.41

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CompuMed, Inc. stock logo
CMPD
CompuMed
-$30K-$0.03N/AN/A-0.85%-1.49%-1.09%5/3/2024 (Estimated)
Akerna Corp. stock logo
KERN
Akerna
-$79.06M-$7.10N/AN/AN/A-339.99%N/A-113.03%N/A
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
-$5.98MN/A0.00N/A2,337.29%-202.89%683.69%N/A
StageZero Life Sciences Ltd. stock logo
SZLSF
StageZero Life Sciences
-$11.41M-$0.12N/AN/A-418.64%N/A-1,872.84%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CompuMed, Inc. stock logo
CMPD
CompuMed
N/AN/AN/AN/AN/A
Akerna Corp. stock logo
KERN
Akerna
N/AN/AN/AN/AN/A
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
N/AN/AN/AN/AN/A
StageZero Life Sciences Ltd. stock logo
SZLSF
StageZero Life Sciences
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CompuMed, Inc. stock logo
CMPD
CompuMed
0.07
2.70
2.31
Akerna Corp. stock logo
KERN
Akerna
N/A
0.10
0.10
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
N/A
0.07
0.07
StageZero Life Sciences Ltd. stock logo
SZLSF
StageZero Life Sciences
N/A
0.04
0.03

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CompuMed, Inc. stock logo
CMPD
CompuMed
N/A
Akerna Corp. stock logo
KERN
Akerna
21.97%
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
N/A
StageZero Life Sciences Ltd. stock logo
SZLSF
StageZero Life Sciences
N/A

Insider Ownership

CompanyInsider Ownership
CompuMed, Inc. stock logo
CMPD
CompuMed
22.00%
Akerna Corp. stock logo
KERN
Akerna
1.20%
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
3.81%
StageZero Life Sciences Ltd. stock logo
SZLSF
StageZero Life Sciences
2.54%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CompuMed, Inc. stock logo
CMPD
CompuMed
81.28 million995,000Not Optionable
Akerna Corp. stock logo
KERN
Akerna
11210.35 million10.23 millionNo Data
MGT Capital Investments, Inc. stock logo
MGTI
MGT Capital Investments
2943.17 million907.24 millionNot Optionable
StageZero Life Sciences Ltd. stock logo
SZLSF
StageZero Life Sciences
40123.53 million120.40 millionNot Optionable

MGTI, KERN, CMPD, and SZLSF Headlines

SourceHeadline
StageZero Life Sciences Ltd: StageZero Life Sciences Provides an Update on Application for Management Cease Trade OrderStageZero Life Sciences Ltd: StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order
finanznachrichten.de - April 5 at 12:07 PM
StageZero Life Sciences Provides an Update on Application for Management Cease Trade OrderStageZero Life Sciences Provides an Update on Application for Management Cease Trade Order
accesswire.com - April 5 at 7:55 AM
StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial ResultsStageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results
accesswire.com - April 2 at 9:30 PM
Stagezero Life Sciences GAAP EPS of -$0.01, revenue of $0.75MStagezero Life Sciences GAAP EPS of -$0.01, revenue of $0.75M
seekingalpha.com - November 15 at 7:45 PM
StageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special MeetingStageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special Meeting
finance.yahoo.com - June 7 at 8:01 PM
Dually-Listed Healthcare Stock Rallies On Q1 ResultsDually-Listed Healthcare Stock Rallies On Q1 Results
theglobeandmail.com - May 17 at 4:33 PM
StageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023StageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023
finance.yahoo.com - May 15 at 2:03 PM
Stagezero Life Sciences GAAP EPS of -$0.09, revenue of $0.7MStagezero Life Sciences GAAP EPS of -$0.09, revenue of $0.7M
msn.com - April 4 at 12:33 AM
StageZero to Issue Q4 2022 Financial Results on Friday March 31StageZero to Issue Q4 2022 Financial Results on Friday March 31
finance.yahoo.com - March 30 at 7:51 PM
StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30
finance.yahoo.com - March 29 at 7:53 PM
Results from METRICs Study Informs Expansion of StageZeros New Care Oncology ProtocolResults from METRICs Study Informs Expansion of StageZero's New Care Oncology Protocol
finance.yahoo.com - February 15 at 5:32 PM
StageZero Life Sciences Ltd: StageZero Life Sciences Announces Extension of Warrants Expiring in January 2023StageZero Life Sciences Ltd: StageZero Life Sciences Announces Extension of Warrants Expiring in January 2023
finanznachrichten.de - January 12 at 7:22 PM
StageZero Life Sciences Announces Extension of Warrants Expiring in January 2023StageZero Life Sciences Announces Extension of Warrants Expiring in January 2023
finance.yahoo.com - January 12 at 7:22 PM
StageZero Life Sciences Ltd. (SZLSF) Q3 2022 Earnings Call TranscriptStageZero Life Sciences Ltd. (SZLSF) Q3 2022 Earnings Call Transcript
seekingalpha.com - November 15 at 3:57 PM
StageZero to Hold Q3 2022 Operational and Financial Results Conference Call on Tuesday November 15, 2022StageZero to Hold Q3 2022 Operational and Financial Results Conference Call on Tuesday November 15, 2022
finance.yahoo.com - November 12 at 11:34 AM
StageZero Life Sciences Ltd: StageZero Announces Solutions for Employers to Help Improve Cancer OutcomesStageZero Life Sciences Ltd: StageZero Announces Solutions for Employers to Help Improve Cancer Outcomes
finanznachrichten.de - August 19 at 11:42 PM
StageZero to Hold Q2 2022 Operational and Financial Results Conference Call on Tuesday August 16, 2022StageZero to Hold Q2 2022 Operational and Financial Results Conference Call on Tuesday August 16, 2022
finance.yahoo.com - August 12 at 1:45 PM
StageZero Life Sciences CFO resignsStageZero Life Sciences CFO resigns
seekingalpha.com - May 26 at 10:23 AM
StageZero Life Sciences Partners with DiagnoseAtHome to Offer Aristotle(R) Multi-Cancer Blood Test in Canada and USAStageZero Life Sciences Partners with DiagnoseAtHome to Offer Aristotle(R) Multi-Cancer Blood Test in Canada and USA
finance.yahoo.com - May 25 at 7:21 PM
StageZero Life Sciences Ltd: StageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational UpdateStageZero Life Sciences Ltd: StageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational Update
finanznachrichten.de - May 17 at 8:00 AM
StageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational UpdateStageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational Update
finance.yahoo.com - May 17 at 8:00 AM
StageZero Life Sciences, Ltd Announces Corporate UpdateStageZero Life Sciences, Ltd Announces Corporate Update
finance.yahoo.com - April 6 at 5:36 PM
StageZero Life Sciences, Ltd Announces Q4 2021 and Year End Financial Results and Operational UpdateStageZero Life Sciences, Ltd Announces Q4 2021 and Year End Financial Results and Operational Update
finance.yahoo.com - April 1 at 8:29 AM
StageZero Life Sciences Ltd: StageZero Life Sciences Launches AVRT in the UKStageZero Life Sciences Ltd: StageZero Life Sciences Launches AVRT in the UK
finanznachrichten.de - March 31 at 10:29 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

CompuMed logo

CompuMed

OTCMKTS:CMPD
CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults. It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis, and therapy monitoring. In addition, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its board-certified specialists; and medical devices. It serves organ procurement organizations, rural healthcare, and correctional healthcare industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California.
Akerna logo

Akerna

NASDAQ:KERN
Akerna Corp. provides enterprise software solutions that enable regulatory compliance and inventory management in the United States and Canada. The company offers MJ Platform for the cannabis, hemp, and CBD industry; and Leaf Data Systems, a government regulatory software. It also provides consulting services to cannabis industry; business intelligence, data analytics and other software related services; and Last Call Analytics, a retail analytics platform. In addition, the company operates Solo, a seed-to-sale tagging and tracking software platform, and Trellis, a cultivation and compliance software platform. Akerna Corp. was founded in 2010 and is headquartered in Denver, Colorado.
MGT Capital Investments logo

MGT Capital Investments

OTCMKTS:MGTI
MGT Capital Investments, Inc. engages in cryptocurrency mining business in the United States. It also leases space to other bitcoin miners; and provides hosting services for owners of mining equipment. The company was incorporated in 1977 and is headquartered in Raleigh, North Carolina.
StageZero Life Sciences logo

StageZero Life Sciences

OTCMKTS:SZLSF
StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood. The company's lead product is Aristotle, a mRNA-based multi-cancer panel test for for the detection of multiple discrete cancers from a single sample of blood. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; Prostate Health Index, a screening test for prostate cancer; BreastSentry, a test to determine a woman's risk for developing breast cancer; and COVID-19 Tests. The company is based in Richmond Hill, Canada.